Lupin receives Form 483 and three observations from USFDA for New Jersey facility
Lupin receives Form 483 and three observations from USFDA for New Jersey facility
Lupin receives Form 483 and three observations from USFDA for New Jersey facility
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
03 May 2026
📎 Sources
CNBC TV18 | https://www.tradingview.com/news/cnbctv:f8ab6a1da094b:0/